icon-folder.gif   Conference Reports for NATAP  
  EASL 48th Annual Meeting
April 24th - 28th 2013
The Netherlands, Amsterdam
Back grey_arrow_rt.gif
ALT Flares During Treatment with Peginterferon Lambda-1a or Peginterferon Alfa in Patients With HBeAg-positive Chronic Hepatitis B Infection (CHB)
  Reported by Jules Levin
EASL 2013 April 24-28 Amsterdam
Chan HL,1 Ahn SH,2 Chang TT,3 Peng CY,4 Wong DK,5 Coffin CS,6 Lim SG,7 Chen PJ,8 Janssen HLA,9 Marcellin P,10 Serfaty L,11 Zeuzem S,12 Hu W,13 Critelli L,13 Wind-Rotolo M,14 Srinivasan, S,13 Lopez-Talavera JC,13 Cooney E13 1Chinese University of Hong Kong, Hong Kong SAR, China; 2Yonsei University Severance Hospital, Seoul, Korea; 3National Chen Kung University Hospital, Tainan, Taiwan; 4China Medical University Hospital, Taichung, Taiwan; 5Toronto Western Hospital University Health Network, Toronto, ON, Canada; 6Liver Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, AB, Canada; 7National University Hospital, Singapore; 8National Taiwan University Hospital, Taipei, Taiwan; 9Erasmus Medical Center, Rotterdam, Netherlands; 10Hopital Beaujon, Clichy, France; 11Hopital Saint Antoine, Paris, France; 12Johann Wolfgang Goethe University, Frankfurt, Germany; 13Bristol-Myers Squibb, Wallingford, CT, USA; 14Bristol-Myers Squibb, Princeton, NJ, USA